128 related articles for article (PubMed ID: 38858309)
1. Implications of Provider Specialty, Test Type, and Demographic Factors on Genetic Testing Outcomes for Patients with Autism Spectrum Disorder.
Harrington CN; Morales A; Bernstein JA; Calderwood L
J Autism Dev Disord; 2024 Jun; ():. PubMed ID: 38858309
[TBL] [Abstract][Full Text] [Related]
2. Comparative yield of molecular diagnostic algorithms for autism spectrum disorder diagnosis in India: evidence supporting whole exome sequencing as first tier test.
Sheth F; Shah J; Jain D; Shah S; Patel H; Patel K; Solanki DI; Iyer AS; Menghani B; Mhatre P; Mehta S; Bajaj S; Patel V; Pandya M; Dhami D; Patel D; Sheth J; Sheth H
BMC Neurol; 2023 Aug; 23(1):292. PubMed ID: 37543562
[TBL] [Abstract][Full Text] [Related]
3. Towards a Change in the Diagnostic Algorithm of Autism Spectrum Disorders: Evidence Supporting Whole Exome Sequencing as a First-Tier Test.
Arteche-López A; Gómez Rodríguez MJ; Sánchez Calvin MT; Quesada-Espinosa JF; Lezana Rosales JM; Palma Milla C; Gómez-Manjón I; Hidalgo Mayoral I; Pérez de la Fuente R; Díaz de Bustamante A; Darnaude MT; Gil-Fournier B; Ramiro León S; Ramos Gómez P; Sierra Tomillo O; Juárez Rufián A; Arranz Cano MI; Villares Alonso R; Morales-Pérez P; Segura-Tudela A; Camacho A; Nuñez N; Simón R; Moreno-García M; Alvarez-Mora MI
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921431
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.
Srivastava S; Love-Nichols JA; Dies KA; Ledbetter DH; Martin CL; Chung WK; Firth HV; Frazier T; Hansen RL; Prock L; Brunner H; Hoang N; Scherer SW; Sahin M; Miller DT;
Genet Med; 2019 Nov; 21(11):2413-2421. PubMed ID: 31182824
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing including targeted gene panel in a diverse clinical population of children with autism spectrum disorder: Findings and implications.
Kalsner L; Twachtman-Bassett J; Tokarski K; Stanley C; Dumont-Mathieu T; Cotney J; Chamberlain S
Mol Genet Genomic Med; 2018 Mar; 6(2):171-185. PubMed ID: 29271092
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genetic analysis of children with unexplained neurodevelopmental delay and neurodevelopmental comorbidities in a Chinese cohort using trio-based whole-exome sequencing.
Wu R; Li X; Meng Z; Li P; He Z; Liang L
Orphanet J Rare Dis; 2024 May; 19(1):205. PubMed ID: 38764027
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel.
Tal-Ben Ishay R; Shil A; Solomon S; Sadigurschi N; Abu-Kaf H; Meiri G; Flusser H; Michaelovski A; Dinstein I; Golan H; Davidovitch N; Menashe I
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052376
[TBL] [Abstract][Full Text] [Related]
8. Genetic Testing in Neurodevelopmental Disorders.
Savatt JM; Myers SM
Front Pediatr; 2021; 9():526779. PubMed ID: 33681094
[TBL] [Abstract][Full Text] [Related]
9. Clinical genetic testing for patients with autism spectrum disorders.
Shen Y; Dies KA; Holm IA; Bridgemohan C; Sobeih MM; Caronna EB; Miller KJ; Frazier JA; Silverstein I; Picker J; Weissman L; Raffalli P; Jeste S; Demmer LA; Peters HK; Brewster SJ; Kowalczyk SJ; Rosen-Sheidley B; McGowan C; Duda AW; Lincoln SA; Lowe KR; Schonwald A; Robbins M; Hisama F; Wolff R; Becker R; Nasir R; Urion DK; Milunsky JM; Rappaport L; Gusella JF; Walsh CA; Wu BL; Miller DT;
Pediatrics; 2010 Apr; 125(4):e727-35. PubMed ID: 20231187
[TBL] [Abstract][Full Text] [Related]
10. Impact of on-site clinical genetics consultations on diagnostic rate in children and young adults with autism spectrum disorder.
Munnich A; Demily C; Frugère L; Duwime C; Malan V; Barcia G; Vidal C; Throo E; Besmond C; Hubert L; Roland-Manuel G; Malen JP; Ferreri M; Hanein S; Thalabard JC; Boddaert N; Assouline M
Mol Autism; 2019; 10():33. PubMed ID: 31406558
[TBL] [Abstract][Full Text] [Related]
11. Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder.
Tammimies K; Marshall CR; Walker S; Kaur G; Thiruvahindrapuram B; Lionel AC; Yuen RK; Uddin M; Roberts W; Weksberg R; Woodbury-Smith M; Zwaigenbaum L; Anagnostou E; Wang Z; Wei J; Howe JL; Gazzellone MJ; Lau L; Sung WW; Whitten K; Vardy C; Crosbie V; Tsang B; D'Abate L; Tong WW; Luscombe S; Doyle T; Carter MT; Szatmari P; Stuckless S; Merico D; Stavropoulos DJ; Scherer SW; Fernandez BA
JAMA; 2015 Sep; 314(9):895-903. PubMed ID: 26325558
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement?
McGrew SG; Peters BR; Crittendon JA; Veenstra-Vanderweele J
J Autism Dev Disord; 2012 Aug; 42(8):1582-91. PubMed ID: 22089167
[TBL] [Abstract][Full Text] [Related]
13. Systematic evaluation of genome sequencing for the diagnostic assessment of autism spectrum disorder and fetal structural anomalies.
Lowther C; Valkanas E; Giordano JL; Wang HZ; Currall BB; O'Keefe K; Pierce-Hoffman E; Kurtas NE; Whelan CW; Hao SP; Weisburd B; Jalili V; Fu J; Wong I; Collins RL; Zhao X; Austin-Tse CA; Evangelista E; Lemire G; Aggarwal VS; Lucente D; Gauthier LD; Tolonen C; Sahakian N; Stevens C; An JY; Dong S; Norton ME; MacKenzie TC; Devlin B; Gilmore K; Powell BC; Brandt A; Vetrini F; DiVito M; Sanders SJ; MacArthur DG; Hodge JC; O'Donnell-Luria A; Rehm HL; Vora NL; Levy B; Brand H; Wapner RJ; Talkowski ME
Am J Hum Genet; 2023 Sep; 110(9):1454-1469. PubMed ID: 37595579
[TBL] [Abstract][Full Text] [Related]
14. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
[TBL] [Abstract][Full Text] [Related]
15. Genetic testing in patients with nonsyndromic autism spectrum disorder and EEG abnormalities with or without epilepsy: Is exome trio-based testing the best clinical approach?
Shillington A; Capal JK
Epilepsy Behav; 2021 Jan; 114(Pt A):107564. PubMed ID: 33243682
[TBL] [Abstract][Full Text] [Related]
16. MLPA is a practical and complementary alternative to CMA for diagnostic testing in patients with autism spectrum disorders and identifying new candidate CNVs associated with autism.
Capkova P; Srovnal J; Capkova Z; Staffova K; Becvarova V; Trkova M; Adamova K; Santava A; Curtisova V; Hajduch M; Prochazka M
PeerJ; 2019; 6():e6183. PubMed ID: 30647996
[TBL] [Abstract][Full Text] [Related]
17. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
[TBL] [Abstract][Full Text] [Related]
18. State of the Art of Genetic Testing for Patients With Autism: A Practical Guide for Clinicians.
Kreiman BL; Boles RG
Semin Pediatr Neurol; 2020 Jul; 34():100804. PubMed ID: 32446438
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
